Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases Financing led by OrbiMed with participation from TCGX, LAV, Cenova Capital and… CISION PRNewswireMay 19, 2026
Press ReleaseNAVER D2SF Invests in Clone Labs, an AI Startup That Predicts User Intent and Decisions – Developing a "User Model" that records and accumulates users’ computer and… CISION PRNewswireMay 19, 2026
Press ReleaseInference Room ships Tack, pledges at least one AI Agent product every month Tack, an Agent-native storage and memory layer, is Inference Room’s first product… CISION PRNewswireMay 19, 2026
Press ReleaseGovee Presents Sanctuary, Reimagining the Modern Home Through Floor Lamps, Colour and Design Created with celebrity interior designer Fawn Galli, the one-night showcase introduced Govee’s… CISION PRNewswireMay 19, 2026
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. Maximum dose reached… CISION PRNewswireMay 19, 2026
Yalla Group Limited Announces Unaudited First Quarter 2026 Financial Results DUBAI, UAE, May 19, 2026 /PRNewswire/ — Yalla Group Limited ("Yalla" or… CISION PRNewswireMay 19, 2026
Press ReleaseOMAN'S SOVEREIGN FUND JOINS GLOBAL TOP PERFORMERS AS RETURNS HIT RECORD HIGH Oman Investment Authority reports USD 7.8bn profit and leads worldwide in public… CISION PRNewswireMay 19, 2026
DAVE & BUSTER'S OPENS IN PERTH AS BRAND CONTINUES GLOBAL EXPANSION Dave & Buster’s makes its Australia debut, expanding its Asia-Pacific footprint Key… CISION PRNewswireMay 19, 2026